Global Immunotherapy Drugs Market Research Report 2021
- Published Date: 2021-01-29
- Report ID: 49082
- Pages: 150
-
Format:
Prudent Markets Predicts that Immunotherapy Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Immunotherapy Drugs Market Overview:
Global Immunotherapy Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Immunotherapy Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Immunotherapy Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Immunotherapy Drugs market in 2020.
Global Immunotherapy Drugs Market Segmentation
By Type, Immunotherapy Drugs market has been segmented into:
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins and Others
By Application, Immunotherapy Drugs market has been segmented into:
Hospitals & Clinics
Ambulatory Surgical Centres and Others.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Immunotherapy Drugs market are:
GlaxoSmithKline (U.K.)
AbbVie
Inc. (U.S.)
F. Hoffmann-La Roche AG (Switzerland)
Amgen
Inc. (U.S.)
AstraZeneca plc (U.K.)
Bristol-Myers Squibb (U.S.)
Novartis International AG (Switzerland)
Eli Lilly and Company (U.S.)
Johnson & Johnson (U.S.)
and Merck & Co.
Inc. (U.S.)
1. Market Overview of Immunotherapy Drugs
1.1 Immunotherapy Drugs Market Overview
1.1.1 Immunotherapy Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Immunotherapy Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Immunotherapy Drugs Historic Market Size by Regions (2015-2020)
1.4 Immunotherapy Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Immunotherapy Drugs Sales Market by Type (2015-2026)
2.1 Global Immunotherapy Drugs Historic Market Size by Type (2015-2020)
2.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2021-2026)
2.3 Monoclonal Antibodies
2.4 Adult Vaccines
2.5 Checkpoint Inhibitors
2.6 Interferons Alpha & Beta
2.7 Interleukins and Others
3. Covid-19 Impact Immunotherapy Drugs Sales Market by Application (2015-2026)
3.1 Global Immunotherapy Drugs Historic Market Size by Application (2015-2020)
3.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2021-2026)
3.3 Hospitals & Clinics
3.4 Ambulatory Surgical Centres and Others.
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Immunotherapy Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Immunotherapy Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Immunotherapy Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Immunotherapy Drugs Business
5.1 GlaxoSmithKline (U.K.)
5.1.1 GlaxoSmithKline (U.K.) Company Profile
5.1.2 GlaxoSmithKline (U.K.) Immunotherapy Drugs Product Specification
5.1.3 GlaxoSmithKline (U.K.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 AbbVie
5.2.1 AbbVie Company Profile
5.2.2 AbbVie Immunotherapy Drugs Product Specification
5.2.3 AbbVie Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Inc. (U.S.)
5.3.1 Inc. (U.S.) Company Profile
5.3.2 Inc. (U.S.) Immunotherapy Drugs Product Specification
5.3.3 Inc. (U.S.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 F. Hoffmann-La Roche AG (Switzerland)
5.4.1 F. Hoffmann-La Roche AG (Switzerland) Company Profile
5.4.2 F. Hoffmann-La Roche AG (Switzerland) Immunotherapy Drugs Product Specification
5.4.3 F. Hoffmann-La Roche AG (Switzerland) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Amgen
5.5.1 Amgen Company Profile
5.5.2 Amgen Immunotherapy Drugs Product Specification
5.5.3 Amgen Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Inc. (U.S.)
5.6.1 Inc. (U.S.) Company Profile
5.6.2 Inc. (U.S.) Immunotherapy Drugs Product Specification
5.6.3 Inc. (U.S.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 AstraZeneca plc (U.K.)
5.7.1 AstraZeneca plc (U.K.) Company Profile
5.7.2 AstraZeneca plc (U.K.) Immunotherapy Drugs Product Specification
5.7.3 AstraZeneca plc (U.K.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Bristol-Myers Squibb (U.S.)
5.8.1 Bristol-Myers Squibb (U.S.) Company Profile
5.8.2 Bristol-Myers Squibb (U.S.) Immunotherapy Drugs Product Specification
5.8.3 Bristol-Myers Squibb (U.S.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Novartis International AG (Switzerland)
5.9.1 Novartis International AG (Switzerland) Company Profile
5.9.2 Novartis International AG (Switzerland) Immunotherapy Drugs Product Specification
5.9.3 Novartis International AG (Switzerland) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Eli Lilly and Company (U.S.)
5.10.1 Eli Lilly and Company (U.S.) Company Profile
5.10.2 Eli Lilly and Company (U.S.) Immunotherapy Drugs Product Specification
5.10.3 Eli Lilly and Company (U.S.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Johnson & Johnson (U.S.)
5.11.1 Johnson & Johnson (U.S.) Company Profile
5.11.2 Johnson & Johnson (U.S.) Immunotherapy Drugs Product Specification
5.11.3 Johnson & Johnson (U.S.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 and Merck & Co.
5.12.1 and Merck & Co. Company Profile
5.12.2 and Merck & Co. Immunotherapy Drugs Product Specification
5.12.3 and Merck & Co. Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Inc. (U.S.)
5.13.1 Inc. (U.S.) Company Profile
5.13.2 Inc. (U.S.) Immunotherapy Drugs Product Specification
5.13.3 Inc. (U.S.) Immunotherapy Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Immunotherapy Drugs Market Size (2015-2026)
6.2 North America Immunotherapy Drugs Key Players in North America (2015-2020)
6.3 North America Immunotherapy Drugs Market Size by Type (2015-2020)
6.4 North America Immunotherapy Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Immunotherapy Drugs Market Size (2015-2026)
7.2 East Asia Immunotherapy Drugs Key Players in North America (2015-2020)
7.3 East Asia Immunotherapy Drugs Market Size by Type (2015-2020)
7.4 East Asia Immunotherapy Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe Immunotherapy Drugs Market Size (2015-2026)
8.2 Europe Immunotherapy Drugs Key Players in North America (2015-2020)
8.3 Europe Immunotherapy Drugs Market Size by Type (2015-2020)
8.4 Europe Immunotherapy Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Immunotherapy Drugs Market Size (2015-2026)
9.2 South Asia Immunotherapy Drugs Key Players in North America (2015-2020)
9.3 South Asia Immunotherapy Drugs Market Size by Type (2015-2020)
9.4 South Asia Immunotherapy Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Immunotherapy Drugs Market Size (2015-2026)
10.2 Southeast Asia Immunotherapy Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia Immunotherapy Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Immunotherapy Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Immunotherapy Drugs Market Size (2015-2026)
11.2 Middle East Immunotherapy Drugs Key Players in North America (2015-2020)
11.3 Middle East Immunotherapy Drugs Market Size by Type (2015-2020)
11.4 Middle East Immunotherapy Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa Immunotherapy Drugs Market Size (2015-2026)
12.2 Africa Immunotherapy Drugs Key Players in North America (2015-2020)
12.3 Africa Immunotherapy Drugs Market Size by Type (2015-2020)
12.4 Africa Immunotherapy Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Immunotherapy Drugs Market Size (2015-2026)
13.2 Oceania Immunotherapy Drugs Key Players in North America (2015-2020)
13.3 Oceania Immunotherapy Drugs Market Size by Type (2015-2020)
13.4 Oceania Immunotherapy Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America Immunotherapy Drugs Market Size (2015-2026)
14.2 South America Immunotherapy Drugs Key Players in North America (2015-2020)
14.3 South America Immunotherapy Drugs Market Size by Type (2015-2020)
14.4 South America Immunotherapy Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Immunotherapy Drugs Market Size (2015-2026)
15.2 Rest of the World Immunotherapy Drugs Key Players in North America (2015-2020)
15.3 Rest of the World Immunotherapy Drugs Market Size by Type (2015-2020)
15.4 Rest of the World Immunotherapy Drugs Market Size by Application (2015-2020)
16 Immunotherapy Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
